Literature DB >> 15466768

The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study.

Chung-Jyi Tsai1, Michael F Leitzmann, Walter C Willett, Edward L Giovannucci.   

Abstract

BACKGROUND: Monounsaturated and polyunsaturated fats act as inhibitors of cholesterol cholelithiasis in animal experiments.
OBJECTIVE: To examine the association between long-term intake of cis unsaturated fats and the incidence of gallstone disease in humans.
DESIGN: Prospective population-based cohort study.
SETTING: The Health Professional Follow-up Study. PARTICIPANTS: 45,756 men, age 40 to 75 years in 1986, who were free of gallstone disease. MEASUREMENTS: Consumption of cis unsaturated fats was assessed starting in 1986 as part of the 131-item semi-quantitative food-frequency questionnaires. Questionnaires were mailed to participants every 2 years. The main outcome measure was self-reported newly diagnosed symptomatic gallstone disease.
RESULTS: During 14 years of follow-up, 2323 new cases of gallstone disease were documented. After adjustment for age and other potential risk factors, the relative risk for gallstone disease among men in the highest quintile of dietary intake of cis unsaturated fats compared with men in the lowest quintile was 0.82 (95% CI, 0.69 to 0.96; P for trend = 0.006). The relative risk among men in the highest quintile of polyunsaturated fat consumption compared with men in the lowest quintile was 0.84 (CI, 0.73 to 0.96; P for trend = 0.01), and the relative risk among men in the highest quintile of monounsaturated fat consumption compared with men in the lowest quintile was 0.83 (CI, 0.70 to 1.00; P for trend = 0.01). LIMITATIONS: Outcomes were restricted to men with cholecystectomy or diagnostically confirmed but unremoved symptomatic gallstones.
CONCLUSIONS: A high intake of polyunsaturated and monounsaturated fats in the context of an energy-balanced diet is associated with a reduced risk for gallstone disease in men. For definitions of terms used in the text, see Glossary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466768     DOI: 10.7326/0003-4819-141-7-200410050-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  16 in total

Review 1.  Targets for current pharmacologic therapy in cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa
Journal:  Gastroenterol Clin North Am       Date:  2010-06       Impact factor: 3.806

2.  Diet-quality scores and the risk of symptomatic gallstone disease: a prospective cohort study of male US health professionals.

Authors:  Janine Wirth; Mingyang Song; Teresa T Fung; Amit D Joshi; Fred K Tabung; Andrew T Chan; Cornelia Weikert; Michael Leitzmann; Walter C Willett; Edward Giovannucci; Kana Wu
Journal:  Int J Epidemiol       Date:  2018-12-01       Impact factor: 7.196

Review 3.  Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?

Authors:  Eldon A Shaffer
Journal:  Curr Gastroenterol Rep       Date:  2005-05

Review 4.  The Role of Diet in the Pathogenesis of Cholesterol Gallstones.

Authors:  Agostino Di Ciaula; Gabriella Garruti; Gema Frühbeck; Maria De Angelis; Ornella de Bari; David Q-H Wang; Frank Lammert; Piero Portincasa
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

5.  A healthy lifestyle pattern and the risk of symptomatic gallstone disease: results from 2 prospective cohort studies.

Authors:  Janine Wirth; Amit D Joshi; Mingyang Song; Dong Hoon Lee; Fred K Tabung; Teresa T Fung; Andrew T Chan; Cornelia Weikert; Michael Leitzmann; Walter C Willett; Edward Giovannucci; Kana Wu
Journal:  Am J Clin Nutr       Date:  2020-09-01       Impact factor: 7.045

6.  Diet and Risk of Cholecystectomy: A Prospective Study Based on the French E3N Cohort.

Authors:  Amélie Barré; Gaëlle Gusto; Claire Cadeau; Franck Carbonnel; Marie-Christine Boutron-Ruault
Journal:  Am J Gastroenterol       Date:  2017-07-25       Impact factor: 10.864

7.  Biliary Polyunsaturated Fatty Acids and Telocytes in Gallstone Disease.

Authors:  Artur Pasternak; Jolanta Bugajska; Mirosław Szura; Jerzy A Walocha; Andrzej Matyja; Mariusz Gajda; Krystyna Sztefko; Krzysztof Gil
Journal:  Cell Transplant       Date:  2016-08-05       Impact factor: 4.064

8.  Evaluation of Factors Affecting the Type of Gallstone.

Authors:  Sonay Baltacı Goktas; Manuk Manukyan; Deniz Selimen
Journal:  Indian J Surg       Date:  2015-07-12       Impact factor: 0.656

9.  Vegetarian diet as a risk factor for symptomatic gallstone disease.

Authors:  T J McConnell; P N Appleby; T J Key
Journal:  Eur J Clin Nutr       Date:  2017-03-08       Impact factor: 4.016

Review 10.  Risk Factors for Cholelithiasis.

Authors:  Mila Pak; Glenda Lindseth
Journal:  Gastroenterol Nurs       Date:  2016 Jul-Aug       Impact factor: 0.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.